These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24668296)

  • 1. Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery.
    Modell V; Knaus M; Modell F; Roifman C; Orange J; Notarangelo LD
    Immunol Res; 2014 Oct; 60(1):132-44. PubMed ID: 24668296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global Network.
    Modell V; Quinn J; Orange J; Notarangelo LD; Modell F
    Immunol Res; 2016 Jun; 64(3):736-53. PubMed ID: 26802037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes.
    Modell V; Orange JS; Quinn J; Modell F
    Immunol Res; 2018 Jun; 66(3):367-380. PubMed ID: 29744770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network.
    Quinn J; Modell V; Orange JS; Modell F
    Allergy Asthma Clin Immunol; 2022 Mar; 18(1):19. PubMed ID: 35246253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From genotype to phenotype. Further studies measuring the impact of a Physician Education and Public Awareness Campaign on early diagnosis and management of primary immunodeficiencies.
    Modell F; Puente D; Modell V
    Immunol Res; 2009; 44(1-3):132-49. PubMed ID: 19140027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jeffrey's insights: Jeffrey Modell Foundation's global genetic sequencing pilot program to identify specific primary immunodeficiency defects to optimize disease management and treatment.
    Quinn J; Modell V; Holle J; Truty R; Aradhya S; Johnson B; Orange J; Modell F
    Immunol Res; 2020 Jun; 68(3):126-134. PubMed ID: 32462469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling strategy to identify patients with primary immunodeficiency utilizing risk management and outcome measurement.
    Modell V; Quinn J; Ginsberg G; Gladue R; Orange J; Modell F
    Immunol Res; 2017 Jun; 65(3):713-720. PubMed ID: 28224361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Expansion of Jeffrey's Insights: Jeffrey Modell Foundation's Genetic Sequencing Program for Primary Immunodeficiency.
    Quinn J; Modell V; Johnson B; Poll S; Aradhya S; Orange JS; Modell F
    Front Immunol; 2022; 13():906540. PubMed ID: 35757720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation.
    Modell V; Gee B; Lewis DB; Orange JS; Roifman CM; Routes JM; Sorensen RU; Notarangelo LD; Modell F
    Immunol Res; 2011 Oct; 51(1):61-70. PubMed ID: 21935653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The four most common pediatric immunodeficiencies.
    Stiehm RE
    Adv Exp Med Biol; 2007; 601():15-26. PubMed ID: 17712988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary immunodeficiencies in Central and Eastern Europe-the power of networking Report on the activity of the Jeffrey Modell Foundation Centers Network in Central and Eastern Europe.
    Sediva A; Bataneant M; Belevtsev M; Blaziene A; Ciznar P; Förster-Waldl E; Kelecic J; Marodi J; Naumova E; Nasrullayeva G; Ress K; Serban M; Sitkauskiene B; Toth B; Modell V; Modell F; Tenembaum V; Marković M; Avcin T
    Immunol Res; 2019 Oct; 67(4-5):358-367. PubMed ID: 31515711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders.
    Lindegren ML; Kobrynski L; Rasmussen SA; Moore CA; Grosse SD; Vanderford ML; Spira TJ; McDougal JS; Vogt RF; Hannon WH; Kalman LV; Chen B; Mattson M; Baker TG; Khoury M
    MMWR Recomm Rep; 2004 Jan; 53(RR-1):1-29. PubMed ID: 14724556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Immunodeficiencies in a Mesoregion of São Paulo, Brazil: Epidemiologic, Clinical, and Geospatial Approach.
    Boton Pereira DH; Primo LS; Pelizari G; Flores E; de Moraes-Vasconcelos D; Condino-Neto A; Prestes-Carneiro LE
    Front Immunol; 2020; 11():862. PubMed ID: 32477349
    [No Abstract]   [Full Text] [Related]  

  • 14. Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe.
    Turley AJ; Gathmann B; Bangs C; Bradbury M; Seneviratne S; Gonzalez-Granado LI; Hackett S; Kutukculer N; Alachkar H; Hambleton S; Ritterbusch H; Kralickova P; Marodi L; Seidel MG; Dueckers G; Roesler J; Huissoon A; Baxendale H; Litzman J; Arkwright PD
    J Clin Immunol; 2015 Feb; 35(2):199-205. PubMed ID: 25663093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Immunodeficiency Diseases in Saudi Arabia: a Tertiary Care Hospital Experience over a Period of Three Years (2010-2013).
    Al-Saud B; Al-Mousa H; Al Gazlan S; Al-Ghonaium A; Arnaout R; Al-Seraihy A; Elshorbagi S; Elsayed N; Afzal J; Al-Dhekri H; Al-Muhsen S
    J Clin Immunol; 2015 Oct; 35(7):651-60. PubMed ID: 26395454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Immunodeficiency Diseases in Aguascalientes, Mexico: Results from an Educational Program.
    Alvarez-Cardona A; Espinosa-Padilla SE; Reyes SO; Ventura-Juarez J; Lopez-Valdez JA; Martínez-Medina L; Santillan-Artolozaga A; Cajero-Avelar A; De Luna-Sosa AR; Torres-Bernal LF; Espinosa-Rosales FJ
    J Clin Immunol; 2016 Apr; 36(3):173-8. PubMed ID: 26898367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive activities to increase recognition of primary immunodeficiency and access to immunoglobulin replacement therapy in Poland.
    Pac M; Bernatowska E
    Eur J Pediatr; 2016 Aug; 175(8):1099-105. PubMed ID: 27357411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis.
    Abolhassani H; Kiaee F; Tavakol M; Chavoshzadeh Z; Mahdaviani SA; Momen T; Yazdani R; Azizi G; Habibi S; Gharagozlou M; Movahedi M; Hamidieh AA; Behniafard N; Nabavi M; Bemanian MH; Arshi S; Molatefi R; Sherkat R; Shirkani A; Amin R; Aleyasin S; Faridhosseini R; Jabbari-Azad F; Mohammadzadeh I; Ghaffari J; Shafiei A; Kalantari A; Mansouri M; Mesdaghi M; Babaie D; Ahanchian H; Khoshkhui M; Soheili H; Eslamian MH; Cheraghi T; Dabbaghzadeh A; Tavassoli M; Kalmarzi RN; Mortazavi SH; Kashef S; Esmaeilzadeh H; Tafaroji J; Khalili A; Zandieh F; Sadeghi-Shabestari M; Darougar S; Behmanesh F; Akbari H; Zandkarimi M; Abolnezhadian F; Fayezi A; Moghtaderi M; Ahmadiafshar A; Shakerian B; Sajedi V; Taghvaei B; Safari M; Heidarzadeh M; Ghalebaghi B; Fathi SM; Darabi B; Bazregari S; Bazargan N; Fallahpour M; Khayatzadeh A; Javahertrash N; Bashardoust B; Zamani M; Mohsenzadeh A; Ebrahimi S; Sharafian S; Vosughimotlagh A; Tafakoridelbari M; Rahimi M; Ashournia P; Razaghian A; Rezaei A; Mamishi S; Parvaneh N; Rezaei N; Hammarström L; Aghamohammadi A
    J Clin Immunol; 2018 Oct; 38(7):816-832. PubMed ID: 30302726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry.
    Aghamohammadi A; Mohammadinejad P; Abolhassani H; Mirminachi B; Movahedi M; Gharagozlou M; Parvaneh N; Zeiaee V; Mirsaeed-Ghazi B; Chavoushzadeh Z; Mahdaviani A; Mansouri M; Yousefzadegan S; Sharifi B; Zandieh F; Hedayat E; Nadjafi A; Sherkat R; Shakerian B; Sadeghi-Shabestari M; Hosseini RF; Jabbari-Azad F; Ahanchian H; Behmanesh F; Zandkarimi M; Shirkani A; Cheraghi T; Fayezi A; Mohammadzadeh I; Amin R; Aleyasin S; Moghtaderi M; Ghaffari J; Arshi S; Javahertrash N; Nabavi M; Bemanian MH; Shafiei A; Kalantari N; Ahmadiafshar A; Khazaei HA; Atarod L; Rezaei N
    J Clin Immunol; 2014 May; 34(4):478-90. PubMed ID: 24659230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of ninety eight Iranian patients with primary immune deficiency in a single tertiary centre.
    Nabavi M; Arshi S; Bemanian MH; Aghamohammadi A; Mansouri D; Hedayat M; Nateghian A; Noorbakhsh S; Ehsanipour F; Faranoush M; Shakeri R; Mesdaghi M; Taghvaei B; Ghalebaghi B; Babaie D; Bahrami A; Fallahpour M; Esmaeilzadeh H; Ali Hamidieh A; Rekabi M; Ahmadian J; Eslami N; Shokri S; Afshar M; Jalali F; Akbarpour N; Molatefi R; Rezaei N
    Allergol Immunopathol (Madr); 2016; 44(4):322-30. PubMed ID: 26803694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.